Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tingyang, Hu"'
Autor:
Haowen Wang, Min Deng, Dexin Cheng, Rui Feng, Hanbo Liu, Tingyang Hu, Dongdong Liu, Cheng Chen, Peilin Zhu, Jian Shen
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThrough preoperative localization, surgeons can easily locate ground glass nodules (GGNs) and effectively control the extent of resection. Therefore, it is necessary to choose an appropriate puncture positioning method. The purpose of this
Externí odkaz:
https://doaj.org/article/0ad72c496f094c76a3cfaaf222bb6e51
Autor:
Tingyang Hu, Randy L. Parrish, Qile Dai, Aron S. Buchman, Shinya Tasaki, David A. Bennett, Nicholas T. Seyfried, Michael P. Epstein, Jingjing Yang
Proteome-wide association study (PWAS) integrating proteomics data with GWAS data is a powerful tool to identify risk genes for complex diseases, which can inform disease mechanisms with genetic effects mediated through protein abundance. We propose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d57ddf7f29c1e5a999de7988b375a92d
https://doi.org/10.1101/2022.12.25.22283936
https://doi.org/10.1101/2022.12.25.22283936
Autor:
Qinming Hou, Wenhao Hu, Zhichao Sun, Wenbin Ji, Xia Wu, Ling Li, Tiefeng Li, Wenqiang Yu, Jian Zhou, Zhiyi Peng, Huanhai Xu, Guohong Cao, Yutang Chen, Jun Han, Wenjiang Gu, Xin Zhang, Jun-Hui Sun, Jiansong Ji, Hongjie Hu, Haijun Du, Jing Huang, Tingyang Hu, Xiaoxi Xie, Shihong Ying, Guoliang Shao, Xiaohua Guo, Dedong Zhu, Jian Fang, Guan-Hui Zhou, Jiaping Zheng, Jun Luo, Changsheng Shi, Zhihai Yu
Publikováno v:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28:249-271
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver cancer. A total of 367 liver cancer patients from 24 medical centers
Autor:
Jiansong Ji, Hongjie Hu, Wenjiang Gu, Wenhao Hu, Ling Li, Zhichao Sun, Xiaoxi Xie, Qinming Hou, Zhiyi Peng, Huanhai Xu, Xiaohua Guo, Shihong Ying, Dedong Zhu, Jun Han, Tingyang Hu, Changsheng Shi, Jian Zhou, Wenqiang Yu, Tiefeng Li, Xin Zhang, Jing Huang, Haijun Du, Yutang Chen, Guohong Cao, Jun-Hui Sun, Zhihai Yu, Guoliang Shao, Guan-Hui Zhou, Xia Wu, Wenbin Ji, Jian Fang, Jun Luo, Jiaping Zheng
Publikováno v:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28:75-94
The purpose of this study was to investigate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) treatment in Chinese hepatocellular carcinoma (HCC) patients and the prognostic factors for treatment response as we
Autor:
Xia Wu, Shihong Ying, Jing Huang, Changsheng Shi, Jiansong Ji, Zhiyi Peng, Guanhui Zhou, Zhichao Sun, Junhui Sun, Wenqiang Yu, Wenhao Hu, Xin Zhang, Jian Zhou, Guoliang Shao, Zhihai Yu, Qinming Hou, Wenjiang Gu, Tiefeng Li, Xiaoxi Xie, Guohong Cao, Haijun Du, Dedong Zhu, Huanhai Xu, Jun Han, Wenbin Ji, Jian Fang, Ling Li, Jiaping Zheng, Jun Luo, Yutang Chen, Tingyang Hu, Hongjie Hu, Xiaohua Guo
Publikováno v:
Translational Cancer Research
Background This study aimed to assess the treatment response, short-term overall survival (OS) and safety profiles of drug-eluting beads transarterial chemoembolization (DEB-TACE) in patients with secondary liver cancer. Methods Fifty-five patients w
Autor:
Jingsong Jiang, Chengbo Yu, Min Deng, Haowen Wang, Tingyang Hu, Xudong Chen, Songxia Yu, Hanbo Liu
Publikováno v:
Science progress. 104(2)
Temporal trends of total liver cancer have been well reported in China, especially the trends caused by hepatitis B (HBV); however, the trends of liver cancer attributable to specific etiologies have rarely been reported in China. Thus, this study ai
Autor:
Huan Zhou, Wenhui Qiu, Tingyang Hu, Qian Zhang, Qingquan Liu, Qing Xu, Yongman Lv, Le Wang, Hui Liu
Publikováno v:
Molecular Medicine Reports. 16:9086-9094
Anti‑glomerular basement membrane glomerulonephritis (anti‑GBM GN) is an autoimmune disease that leads to severe and rapidly progressive renal injury. Inhibition of DNA‑binding factor 3 (ID3) serves a key role in autoimmune diseases, such as as
Autor:
Zhiyi, Peng, Guohong, Cao, Qinming, Hou, Ling, Li, Shihong, Ying, Junhui, Sun, Guanhui, Zhou, Jian, Zhou, Xin, Zhang, Wenbin, Ji, Zhihai, Yu, Tiefeng, Li, Dedong, Zhu, Wenhao, Hu, Jiansong, Ji, Haijun, Du, Changsheng, Shi, Xiaohua, Guo, Jian, Fang, Jun, Han, Wenjiang, Gu, Xiaoxi, Xie, Zhichao, Sun, Huanhai, Xu, Xia, Wu, Tingyang, Hu, Jing, Huang, Hongjie, Hu, Jiaping, Zheng, Jun, Luo, Yutang, Chen, Wenqiang, Yu, Guoliang, Shao
Publikováno v:
Oncology Research
This study aimed to investigate the efficacy, safety, and prognostic factors of drug-eluting beads transarterial chemoembolization (DEB-TACE) in treating Chinese patients with liver cancer. A total of 367 liver cancer patients from 24 medical centers
Autor:
Junhui, Sun, Guanhui, Zhou, Xiaoxi, Xie, Wenjiang, Gu, Jing, Huang, Dedong, Zhu, Wenhao, Hu, Qinming, Hou, Changsheng, Shi, Tiefeng, Li, Xin, Zhang, Wenbin, Ji, Shihong, Ying, Zhiyi, Peng, Jian, Zhou, Zhihai, Yu, Jiansong, Ji, Haijun, Du, Xiaohua, Guo, Jian, Fang, Jun, Han, Huanhai, Xu, Zhichao, Sun, Wenqiang, Yu, Guoliang, Shao, Xia, Wu, Hongjie, Hu, Ling, Li, Jiaping, Zheng, Jun, Luo, Yutang, Chen, Guohong, Cao, Tingyang, Hu
Publikováno v:
Oncology Research
The purpose of this study was to investigate the efficacy and safety of drug-eluting beads transarterial chemoembolization (DEB-TACE) treatment in Chinese hepatocellular carcinoma (HCC) patients and the prognostic factors for treatment response as we
Autor:
Qing Xu, Huiquan Liu, Ya-Qun Zhou, Yongman Lv, Hui Liu, Qingquan Liu, Tingyang Hu, Wenhui Qiu, Kongming Wu
Publikováno v:
Oncotarget
// Qing-Quan Liu 1 , Ya-Qun Zhou 2 , Hui-Quan Liu 3 , Wen-Hui Qiu 1 , Hui Liu 1 , Ting-Yang Hu 1 , Qing Xu 1 , Yong-Man Lv 1 , Kong-Ming Wu 3 1 Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech